Jump to content


Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Photo

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis (SSc)


  • Please log in to reply
No replies to this topic

#1 Jeannie McClelland

Jeannie McClelland

    Senior Gold Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 1,696 posts
  • Location:in the Rocky Mountains of the USA

Posted 04 February 2011 - 04:49 PM

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis (SSc). Functional autoimmunity directed at angiotensin II type 1 receptor (AT1R) and endothelin-1 type A receptor (ETAR) is common in patients with SSc. AT1R and ETAR autoantibodies could contribute to disease pathogenesis and may serve as biomarkers for risk assessment of disease progression. Gabriela Riemekasten, Annals of Rheumatic Diseases, 15 November 2010. (Also see: Autoantibodies)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles
Jeannie McClelland
(Retired) ISN Director of Support Services
(Retired) ISN Sclero Forums Manager
(Retired) ISN Blog Manager
(Retired) ISN Assistant News Guide
(Retired) ISN Artist
International Scleroderma Network